Picture of SCI Pharmtech logo

4119 SCI Pharmtech Cashflow Statement

0.000.00%
tw flag iconLast trade - 00:00
HealthcareConservativeSmall CapNeutral

Annual cashflow statement for SCI Pharmtech, fiscal year end - December 31st, TWD millions except per share, conversion factor applied.

2019
December 31st
2020
December 31st
2021
December 31st
2022
December 31st
2023
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:Annual Audited AccountsAnnual Audited AccountsAnnual Audited AccountsAnnual Audited AccountsAnnual Audited Accounts
Standards:
IFRS
IFRS
IFRS
IFRS
IFRS
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line71145565.5388364
Depreciation
Amortisation
Non-Cash Items-10.55775.36-73.237.5
Unusual Items
Equity in Net Earnings/Losses
Other Non-Cash Items
Changes in Working Capital-45.8-194146-109-331
Change in Accounts Receivable
Change in Inventories
Change in Other Assets
Change in Accounts Payable
Change in Accrued Expenses
Change in Other Liabilities
Other Operating Cash Flow
Cash from Operating Activities792972280297216
Capital Expenditures-204-218-775-1,168-1,029
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items-59-211235158163
Acquisition of Business
Sale of Fixed Assets
Sale/Maturity of Investment
Purchase of Investments
Other Investing Cash Flow
Cash from Investing Activities-263-429-540-1,009-866
Financing Cash Flow Items10
Other Financing Cash Flow
Total Cash Dividends Paid
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities-336-463-41.55471,426
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash19279.5-301-165775